Literature DB >> 15921179

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in obese Argentinean children and adolescents.

Carmen S Mazza1, Blanca Ozuna, Andrea Gabriela Krochik, María Beatriz Araujo.   

Abstract

The aim of this study was to evaluate the prevalence of type 2 diabetes mellitus (DM2) and impaired glucose tolerance (IGT) in obese children and adolescents and to examine insulin resistance and insulin secretion. We studied 427 asymptomatic obese patients. DM2 and IGT were diagnosed by an oral glucose tolerance test. Insulin resistance and P-cell function were assessed by using homeostasis model assessment (HOMA), insulin/glucose index (I/GI), fasting insulin and insulin sensitivity index (ISI-composite). Thirty patients showed IGT (7%) and seven had DM2 (1.6%). The mean age was 10.7 +/- 3.5 years, the diabetic group being significantly older than the normal group (p < 0.01). The mean body mass index was 30 +/- 5.3 kg/m2 without significant differences between groups. beta-Cell function declined significantly in the patients with IGT and DM2, and insulin resistance increased significantly. Given the rather high prevalence of glucose metabolism impairment, children with obesity should undergo glucose tolerance testing for appropriate therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921179     DOI: 10.1515/JPEM.2005.18.5.491

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

Review 1.  Development of type 2 diabetes in children and adolescents.

Authors:  Ram Weiss; Sara E Taksali; Sonia Caprio
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

2.  Obesity in Irish youth: epidemiology and implications.

Authors:  F M Finucane
Journal:  Ir J Med Sci       Date:  2009-06-03       Impact factor: 1.568

3.  Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment.

Authors:  Alfredo Halpern; Marcio C Mancini; Maria Eliane C Magalhães; Mauro Fisberg; Rosana Radominski; Marcelo C Bertolami; Adriana Bertolami; Maria Edna de Melo; Maria Teresa Zanella; Marcia S Queiroz; Marcia Nery
Journal:  Diabetol Metab Syndr       Date:  2010-08-18       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.